| 000 | 00915 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513092706.0 | ||
| 264 | 0 | _c19960827 | |
| 008 | 199608s 0 0 jpn d | ||
| 022 | _a0021-5384 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShimoyama, M | |
| 245 | 0 | 0 |
_a[Drug therapy of hematologic malignancy]. _h[electronic resource] |
| 260 |
_bNihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine _cMar 1996 |
||
| 300 |
_a337-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 773 | 0 |
_tNihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine _gvol. 85 _gno. 3 _gp. 337-41 |
|
| 999 |
_c8688323 _d8688323 |
||